Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin degludec and insulin aspart trial in Japan (jRCT1080224515)
jRCT1080224515Completed
- Sponsor
- Novo Nordisk
- Start
- Jan 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Trial of insulin degludec and insulin aspart in diabetes mellitus (DM), sponsored by Novo Nordisk. Started Jan 2019; status: completed.
02
Drugs
insulin degludecinsulin aspart
03
Conditions
diabetes mellitus (DM)
Beyond the preview
Go deeper on jRCT1080224515.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080224515.